[1]
Y. Sirchak, “Clinical efficacy of the symbiotic drug Lotardi-A in the complex therapy of patients with irritable bowel syndrome in metabolic-associated fatty liver disease”, ScienceRise: Medical Science, no. 1 (62), pp. 4–13, May 2025.